시장보고서
상품코드
2144815

폴리락틱코글리콜산(PLGA) 시장(2026-2030년)

Global Poly (Lactic-Co-Glycolic Acid) (PLGA) Market 2026-2030

발행일: | 리서치사: 구분자 TechNavio | 페이지 정보: 영문 319 Pages | 배송안내 : 즉시배송

    
    
    




가격
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트 등을 복사 및 붙여넣기 할 수 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 2,500 금액 안내 화살표 ₩ 3,348,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,000 금액 안내 화살표 ₩ 5,357,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 폴리락틱코글리콜산(PLGA) 시장은 2025년부터 2030년까지 1억 7,210만 300달러 증가하고, 예측 기간 동안 CAGR은 9.9%가 될 전망입니다.

본 보고서는 전 세계 폴리락틱코글리콜산(PLGA) 시장에 대해 종합적인 분석, 시장 규모 및 전망, 동향, 성장 요인, 과제는 물론 약 25개 업체에 대한 분석을 제공합니다.

본 보고서는 현재의 시장 상황, 최신 시장 동향 및 촉진요인, 그리고 전반적인 시장 환경에 대한 최신 분석을 제공합니다. 이 시장의 성장은 지속성 주사제의 수요 확대, 재생의료용 스캐폴드 용도의 증가, 그리고 표적형 나노의료 플랫폼의 발전에 의해 주도되고 있습니다.

본 조사는 업계 주요 관계자로부터 얻은 정보를 포함한 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 본 보고서에는 주요 기업 분석 외에도 종합적인 시장 규모 데이터, 지역별 분석을 포함한 부문별 데이터, 그리고 공급업체 현황이 포함되어 있습니다. 보고서에는 과거 데이터 및 예측 데이터가 포함되어 있습니다.

시장 범위
기준 연도 2025년
종료 연도 2030년
조사 기간 2026-2030년
성장 모멘텀 가속
2026년 전년 대비 9.2%
CAGR 9.9%
증가액 1억 7,210만 300달러

본 조사에서는 향후 수년간 전 세계 폴리락틱코글리콜산(PLGA) 시장의 성장을 견인할 주요 요인 중 하나로 초고순도 단량체 배합으로의 전환이 꼽히고 있습니다. 또한, 미세유체 연속 제조 기술의 도입과 경피 미세바늘 전달 기술의 개발로 인해 시장에서 상당한 수요가 예상됩니다.

목차

제1장 주요 요약

제2장 Technavio 분석

제3장 시장 구도

제4장 시장 규모

제5장 시장 규모 실적

제6장 정성 분석

제7장 Five Forces 분석

제8장 시장 세분화 : 용도별

제9장 시장 세분화 : 유형별

제10장 시장 세분화 : 제품 유형별

제11장 고객 상황

제12장 지역별 상황

제13장 촉진요인, 과제, 기회

제14장 경쟁 구도

제15장 경쟁 분석

제16장 부록

KSM 26.10.21

The global poly (lactic-co-glycolic acid) (PLGA) market is forecasted to grow by USD 172100.3 thousand during 2025-2030, accelerating at a CAGR of 9.9% during the forecast period. The report on the global poly (lactic-co-glycolic acid) (PLGA) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by expanding long acting injectable drug demand, rising regenerative medicine scaffolding applications, advancements in targeted nanomedicine platforms.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year2025
End Year2030
Series Year2026-2030
Growth MomentumAccelerate
YOY 20269.2%
CAGR9.9%
Incremental Value$172100.3 thousand

Technavio's global poly (lactic-co-glycolic acid) (PLGA) market is segmented as below:

By Application

  • Personal care and dermatology
  • Suture
  • Fracture fixation
  • Others

By Type

  • PLGA 50/50
  • PLGA 75/25
  • PLGA 85/15
  • PLGA 65/35

By Product Type

  • Microspheres
  • Nanoparticles
  • Films
  • Hydrogels
  • Others

Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • The Netherlands
  • APAC
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
  • South America
    • Brazil
    • Argentina
    • Chile
  • Middle East and Africa
    • UAE
    • South Africa
    • Turkey
  • Rest of World (ROW)

This study identifies the shift towards ultrapure monomer formulations as one of the prime reasons driving the global poly (lactic-co-glycolic acid) (PLGA) market growth during the next few years. Also, adoption of microfluidic continuous manufacturing and development of transdermal microneedle delivery will lead to sizable demand in the market.

The report on the global poly (lactic-co-glycolic acid) (PLGA) market covers the following areas:

  • Global poly (lactic-co-glycolic acid) (PLGA) market sizing
  • Global poly (lactic-co-glycolic acid) (PLGA) market forecast
  • Global poly (lactic-co-glycolic acid) (PLGA) market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global poly (lactic-co-glycolic acid) (PLGA) market vendors that include Akina Inc., Ashland Inc., Bezwada Biomedical LLC, BrightCN, Corbion N.V., Creative PEGWorks, DSM Firmenich AG, Evonik Industries AG, Geon Performance Solutions, Gunze Ltd., Kureha Corp., Merck KGaA, Mitsui Chemicals Inc., Nanosoft Polymers, Poly Med Inc., Polysciences Inc., RXNDT International, Science and Bio Material, SEQENS GROUP, Toray Industries Inc.. Also, the global poly (lactic-co-glycolic acid) (PLGA) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market by Geography
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Market Segmentation by Type
    • Executive Summary - Chart on Market Segmentation by Product Type
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
  • 2.3 Factors of disruption
  • 2.4 Impact of drivers and challenges

3 Market Landscape

  • 3.1 Market ecosystem
  • 3.2 Market characteristics
  • 3.3 Value chain analysis

4 Market Sizing

  • 4.1 Market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2025
  • 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

  • 5.1 Global Poly (Lactic-Co-Glycolic Acid) (PLGA) Market 2020 - 2024
    • Historic Market Size - Data Table on Global Poly (Lactic-Co-Glycolic Acid) (PLGA) Market 2020 - 2024 ($ thousand)
  • 5.2 Application segment analysis 2020 - 2024
    • Historic Market Size - Application Segment 2020 - 2024 ($ thousand)
  • 5.3 Type segment analysis 2020 - 2024
    • Historic Market Size - Type Segment 2020 - 2024 ($ thousand)
  • 5.4 Product Type segment analysis 2020 - 2024
    • Historic Market Size - Product Type Segment 2020 - 2024 ($ thousand)
  • 5.5 Geography segment analysis 2020 - 2024
    • Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
  • 5.6 Country segment analysis 2020 - 2024
    • Historic Market Size - Country Segment 2020 - 2024 ($ thousand)

6 Qualitative Analysis

  • 6.1 Impact of AI on global poly (lactic-co-glycolic acid) (PLGA) market
  • 6.2 Impact of geopolitical conflicts on global poly (lactic-co-glycolic acid) (PLGA) market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2025 and 2030
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2025 and 2030
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2025 and 2030
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2025 and 2030
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2025 and 2030
  • 7.7 Market condition

8 Market Segmentation by Application

  • 8.1 Market segments
  • 8.2 Comparison by Application
  • 8.3 Personal care and dermatology - Market size and forecast 2025-2030
  • 8.4 Suture - Market size and forecast 2025-2030
  • 8.5 Fracture fixation - Market size and forecast 2025-2030
  • 8.6 Others - Market size and forecast 2025-2030
  • 8.7 Market opportunity by Application
    • Market opportunity by Application ($ thousand)

9 Market Segmentation by Type

  • 9.1 Market segments
  • 9.2 Comparison by Type
  • 9.3 PLGA 50/50 - Market size and forecast 2025-2030
  • 9.4 PLGA 75/25 - Market size and forecast 2025-2030
  • 9.5 PLGA 85/15 - Market size and forecast 2025-2030
  • 9.6 PLGA 65/35 - Market size and forecast 2025-2030
  • 9.7 Market opportunity by Type
    • Market opportunity by Type ($ thousand)

10 Market Segmentation by Product Type

  • 10.1 Market segments
  • 10.2 Comparison by Product Type
  • 10.3 Microspheres - Market size and forecast 2025-2030
  • 10.4 Nanoparticles - Market size and forecast 2025-2030
  • 10.5 Films - Market size and forecast 2025-2030
  • 10.6 Hydrogels - Market size and forecast 2025-2030
  • 10.7 Others - Market size and forecast 2025-2030
  • 10.8 Market opportunity by Product Type
    • Market opportunity by Product Type ($ thousand)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
  • 12.2 Geographic comparison
  • 12.3 North America - Market size and forecast 2025-2030
    • 12.3.1 US - Market size and forecast 2025-2030
    • 12.3.2 Canada - Market size and forecast 2025-2030
    • 12.3.3 Mexico - Market size and forecast 2025-2030
  • 12.4 Europe - Market size and forecast 2025-2030
    • 12.4.1 Germany - Market size and forecast 2025-2030
    • 12.4.2 UK - Market size and forecast 2025-2030
    • 12.4.3 France - Market size and forecast 2025-2030
    • 12.4.4 Italy - Market size and forecast 2025-2030
    • 12.4.5 Spain - Market size and forecast 2025-2030
    • 12.4.6 The Netherlands - Market size and forecast 2025-2030
  • 12.5 APAC - Market size and forecast 2025-2030
    • 12.5.1 China - Market size and forecast 2025-2030
    • 12.5.2 Japan - Market size and forecast 2025-2030
    • 12.5.3 India - Market size and forecast 2025-2030
    • 12.5.4 South Korea - Market size and forecast 2025-2030
    • 12.5.5 Australia - Market size and forecast 2025-2030
    • 12.5.6 Indonesia - Market size and forecast 2025-2030
  • 12.6 South America - Market size and forecast 2025-2030
    • 12.6.1 Brazil - Market size and forecast 2025-2030
    • 12.6.2 Argentina - Market size and forecast 2025-2030
    • 12.6.3 Chile - Market size and forecast 2025-2030
  • 12.7 Middle East and Africa - Market size and forecast 2025-2030
    • 12.7.1 Saudi Arabia - Market size and forecast 2025-2030
    • 12.7.2 UAE - Market size and forecast 2025-2030
    • 12.7.3 South Africa - Market size and forecast 2025-2030
    • 12.7.4 Israel - Market size and forecast 2025-2030
    • 12.7.5 Turkey - Market size and forecast 2025-2030
  • 12.8 Market opportunity by geography
    • Market opportunity by geography ($ thousand)
    • Data Tables on Market opportunity by geography ($ thousand)

13 Drivers, Challenges, and Opportunity

  • 13.1 Market drivers
    • Expanding long acting injectable drug demand
    • Rising regenerative medicine scaffolding applications
    • Advancements in targeted nanomedicine platforms
  • 13.2 Market challenges
    • Complex batch consistency and scaling hurdles
    • Initial burst release in delivery formulations
    • High cost raw material supply constraints
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2025 and 2030
  • 13.4 Market opportunities
    • Shift towards ultrapure monomer formulations
    • Adoption of microfluidic continuous manufacturing
    • Development of transdermal microneedle delivery

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 Ashland Inc.
    • Ashland Inc. - Overview
    • Ashland Inc. - Business segments
    • Ashland Inc. - Key news
    • Ashland Inc. - Key offerings
    • Ashland Inc. - Segment focus
    • SWOT
  • 15.5 Bezwada Biomedical LLC
    • Bezwada Biomedical LLC - Overview
    • Bezwada Biomedical LLC - Product / Service
    • Bezwada Biomedical LLC - Key offerings
    • SWOT
  • 15.6 BrightCN
    • BrightCN - Overview
    • BrightCN - Product / Service
    • BrightCN - Key offerings
    • SWOT
  • 15.7 Corbion N.V.
    • Corbion N.V. - Overview
    • Corbion N.V. - Business segments
    • Corbion N.V. - Key offerings
    • Corbion N.V. - Segment focus
    • SWOT
  • 15.8 Creative PEGWorks
    • Creative PEGWorks - Overview
    • Creative PEGWorks - Product / Service
    • Creative PEGWorks - Key offerings
    • SWOT
  • 15.9 DSM Firmenich AG
    • DSM Firmenich AG - Overview
    • DSM Firmenich AG - Business segments
    • DSM Firmenich AG - Key offerings
    • DSM Firmenich AG - Segment focus
    • SWOT
  • 15.10 Evonik Industries AG
    • Evonik Industries AG - Overview
    • Evonik Industries AG - Business segments
    • Evonik Industries AG - Key news
    • Evonik Industries AG - Key offerings
    • Evonik Industries AG - Segment focus
    • SWOT
  • 15.11 Geon Performance Solutions
    • Geon Performance Solutions - Overview
    • Geon Performance Solutions - Product / Service
    • Geon Performance Solutions - Key offerings
    • SWOT
  • 15.12 Gunze Ltd.
    • Gunze Ltd. - Overview
    • Gunze Ltd. - Product / Service
    • Gunze Ltd. - Key offerings
    • SWOT
  • 15.13 Kureha Corp.
    • Kureha Corp. - Overview
    • Kureha Corp. - Business segments
    • Kureha Corp. - Key offerings
    • Kureha Corp. - Segment focus
    • SWOT
  • 15.14 Merck KGaA
    • Merck KGaA - Overview
    • Merck KGaA - Business segments
    • Merck KGaA - Key news
    • Merck KGaA - Key offerings
    • Merck KGaA - Segment focus
    • SWOT
  • 15.15 Mitsui Chemicals Inc.
    • Mitsui Chemicals Inc. - Overview
    • Mitsui Chemicals Inc. - Business segments
    • Mitsui Chemicals Inc. - Key offerings
    • Mitsui Chemicals Inc. - Segment focus
    • SWOT
  • 15.16 Science and Bio Material
    • Science and Bio Material - Overview
    • Science and Bio Material - Product / Service
    • Science and Bio Material - Key offerings
    • SWOT
  • 15.17 SEQENS GROUP
    • SEQENS GROUP - Overview
    • SEQENS GROUP - Product / Service
    • SEQENS GROUP - Key offerings
    • SWOT
  • 15.18 Toray Industries Inc.
    • Toray Industries Inc. - Overview
    • Toray Industries Inc. - Business segments
    • Toray Industries Inc. - Key news
    • Toray Industries Inc. - Key offerings
    • Toray Industries Inc. - Segment focus
    • SWOT

16 Appendix

  • 16.1 Scope of the report
    • Market definition
    • Objectives
    • Notes and caveats
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기